Whitepaper
13 May 2021

Catalent Clinical Supply - The Product Development Superhighway: Leveraging End-to-End Solutions for Market Success

PDF 1.5 MB

Formulating drugs for optimal stability and bioavailability is fundamental to the development of new pharmaceutical products. Once developed, these products must then be delivered to patients in the clinic. Since pharmaceutical scientists often work in isolation from the supply chain and clinical operations personnel responsible for clinical packaging and delivery of patient kits, there is an ever-present risk of potentially foreseeable and avoidable problems occurring further down the line. This article explores the benefits of a more integrated approach in which the chemical, manufacturing, and controls (CMC) teams and clinical teams work together at an early stage to achieve greater success for both the development program and patients.

Content provided by our supplier

Catalent Pharma Solutions

  • US
  • 2015
    On CPhI since
  • 1
    Certificates
  • 5000+
    Employees

Other Content from Catalent Pharma Solutions